Month: January 2026

Deal to Expand AlphaTON’s Deployment of Telegram’s Cocoon AI Confidential Compute, Achieving 3.82x Projected Equity Multiple New York, NY, Jan. 12, 2026 (GLOBE NEWSWIRE) — AlphaTON Capital Corp (NASDAQ: ATON), the world’s leading public technology company scaling the Telegram super app, with an addressable market of 1 billion monthly active users, today reports the signing and closing of a strategic $46 million AI compute infrastructure deal, adding 576 NVIDIA B300 chips, a half cluster, to its books. This deployment, scheduled for delivery next month in February, is projected to deliver a 27% IRR, 282% ROI, and a Net Present Value of $11 million, building on AlphaTON’s existing $20 million in assets on its balance sheet.  AlphaTON is pioneering a new category in artificial intelligence: providing privacy-preserving, decentralized...

The Waterfront Smart Home Community Lake Shore Reserve is Located on the Hickory Lake in Granite Falls, North Carolina Nearby Microsoft’s Upcoming 1,385 Acres Mega Park and will include 140 Luxury Smart Single-Family Homes  SKYX is Expected to Supply its All-In-One Smart Home Platform Hub Comprising its NVIDIA AI Ecosystem with over 10,000 Units Including its Advanced Smart Plug & Play Technologies, Ceiling Lighting, Ceiling Fans, Recessed Lights, Down Lights, EXIT Signs, Emergency Lights, Indoor and Outdoor Wall Lights Among Other Advanced Smart Products SKYX’s Technologies Expansion Provides Additional Opportunities for Future Recurring Revenues Through Interchangeability, Upgrades, AI Services, Monitoring, Subscriptions, Among Others MIAMI, Jan. 12, 2026 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX...

Tel Aviv, Israel, Jan. 12, 2026 (GLOBE NEWSWIRE) — As global security threats become increasingly sophisticated, the demand for advanced, AI-driven homeland security solutions has never been higher. KeepZone AI Inc. (“KeepZone”), a wholly owned subsidiary of Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), was launched as part of Jeffs’ Brands’ strategic expansion beyond its legacy date-driven e-commerce operations into the global homeland security sector through advanced artificial intelligence (“AI”)-driven solutions. KeepZone aims to integrate multiple innovative systems into seamless, multi-layered ecosystems designed to address modern challenges such as border protection, critical infrastructure safeguarding, and public safety. Background and Strategic Motive Jeffs’ Brands...

ATHENS, Greece, Jan. 12, 2026 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Bunge SA, Geneva, for one of its Ultramax dry bulk vessels, the m/v DSI Altair. The gross charter rate is US$14,750 per day, minus a 5.00% commission paid to third parties, for a period until minimum January 15, 2027 up to maximum March 30, 2027. The charter is expected to commence on January 17, 2026. The “DSI Altair” is a 60,309 dwt Ultramax dry bulk vessel built in 2016. The employment of “DSI Altair” is anticipated to generate a total of approximately US$5.30 million of gross revenue for the minimum scheduled period...

BASTROP, Texas, Jan. 12, 2026 (GLOBE NEWSWIRE) — JA Development & Construction, acquired last year by Suntex Enterprises, Inc. (OTC: SNTX), announced today that it has secured a multi-year development agreement in Bastrop, Texas, establishing the company as a long-term construction and maintenance partner supporting the ongoing expansion of one of the largest technology companies in the world. The agreement covers ongoing site maintenance, infrastructure support, and new construction activities, placing JA Development & Construction directly within a development environment defined by scale, precision, and long-term growth. The work is structured to support active operations today while enabling future expansion, creating a durable pipeline of work over multiple years. This partnership represents a step-change in the...

VERO BEACH, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced that George Ng, Chief Executive Officer, and Patrick Lin, Chief Business & Strategy Officer and Founder, will attend the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, California. During the conference, Mr. Ng and Mr. Lin will be available for one-on-one meetings with investors and potential partners to discuss Processa’s clinical pipeline, including the ongoing Phase 2 study evaluating NGC-Cap in patients with advanced or metastatic breast cancer. Preliminary Phase 2 data have demonstrated that NGC-Cap increases exposure to capecitabine’s cancer-killing metabolites while...

Casino Salem to be renamed Rockingham Grand CasinoRockingham Grand CasinoRendering of exterior entrance to Rockingham Grand CasinoRockingham Grand CasinoRendering of southwest exterior of Rockingham Grand CasinoRockingham Grand CasinoRebranded logo of Rockingham Grand CasinoLOUISVILLE, Ky., Jan. 12, 2026 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or “the Company”) (Nasdaq: CHDN) announced today new development details related to its charitable gaming facility in Salem, New Hampshire. The company currently operates Casino Salem, located in 19,000 square-feet within The Mall at Rockingham Park. Casino Salem will be redeveloped as Rockingham Grand Casino. Rockingham Grand Casino will occupy 160,000 square-feet over three floors and will feature 825 historical racing machines, 32 table games,...

The planned collaboration highlights the role of complete genome resolution in scaling n-of-1 therapeutic models MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced plans to pursue a strategic collaboration with the n-Lorem Foundation and EspeRare that we believe will position long-read whole-genome sequencing as enabling infrastructure to support the development of individualized antisense oligonucleotide (ASO) therapies for ultra-rare genetic diseases. Under the proposed collaboration, PacBio will provide its scientific expertise, and the collaboration will utilize PacBio’s long-read whole genome sequencing technology, to study the design, feasibility assessment, and molecular characterization of ASO therapies – to help...